Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Meningococcal molecular mimicry and the search for an ideal vaccine.

Griffiss JM, Yamasaki R, Estabrook M, Kim JJ.

Trans R Soc Trop Med Hyg. 1991;85 Suppl 1:32-6. Review.

PMID:
1725072
2.

Meningococcal vaccines--present and future.

Zollinger WD, Moran E.

Trans R Soc Trop Med Hyg. 1991;85 Suppl 1:37-43. Review.

PMID:
1803695
3.

Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.

Braun JM, Beuth J, Blackwell CC, Giersen S, Higgins PG, Tzanakaki G, Unverhau H, Weir DM.

Vaccine. 2004 Feb 17;22(7):898-908.

PMID:
15040943
4.

[Immune response to anti-meningococcal vaccines].

Milagres LG, Melles CE.

Rev Saude Publica. 1993 Jun;27(3):221-6. Review. Portuguese.

PMID:
8115838
5.
6.

Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis.

Troncoso G, Sánchez S, Criado MT, Ferreirós CM.

FEMS Immunol Med Microbiol. 2002 Sep 6;34(1):9-15.

7.

Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Diaz Romero J, Outschoorn IM.

Clin Microbiol Rev. 1994 Oct;7(4):559-75. Review.

8.

The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.

Jennings HJ.

Contrib Microbiol Immunol. 1989;10:151-65. Review. No abstract available.

PMID:
2479499
9.

Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.

Rune Andersen S, Kolberg J, Høiby EA, Namork E, Caugant DA, Oddvar Frøholm L, Jantzen E, Bjune G.

Microb Pathog. 1997 Sep;23(3):139-55.

PMID:
9281472
10.

In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica.

Sánchez S, Troncoso G, Criado MT, Ferreirós C.

Vaccine. 2002 Jul 26;20(23-24):2957-63.

PMID:
12126908
11.

Cellular immune responses to Neisseria meningitidis in children.

Pollard AJ, Galassini R, Rouppe van der Voort EM, Hibberd M, Booy R, Langford P, Nadel S, Ison C, Kroll JS, Poolman J, Levin M.

Infect Immun. 1999 May;67(5):2452-63.

12.

Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Verheul AF, Snippe H, Poolman JT.

Microbiol Rev. 1993 Mar;57(1):34-49. Review.

13.

Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.

Fischer M, Carlone GM, Holst J, Williams D, Stephens DS, Perkins BA.

Vaccine. 1999 May 14;17(19):2377-83.

PMID:
10392619
14.

Neisseria meningitidis: vaccines and vaccine candidates.

Al'Aldeen AA, Cartwright KA.

J Infect. 1996 Nov;33(3):153-7. Review. No abstract available.

PMID:
8945702
15.

Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine.

Milagres LG, Cristina M, Brandileone MC, Sacchi CT, Vieira VS, Zanella RC, Frasch CE.

FEMS Immunol Med Microbiol. 1996 Jan;13(1):9-17.

PMID:
8821393
16.

Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.

Litt DJ, Savino S, Beddek A, Comanducci M, Sandiford C, Stevens J, Levin M, Ison C, Pizza M, Rappuoli R, Kroll JS.

J Infect Dis. 2004 Oct 15;190(8):1488-97. Epub 2004 Sep 9.

17.

Meningococcal vaccines.

Bethell D, Pollard AJ.

Expert Rev Vaccines. 2002 Jun;1(1):75-84. Review.

PMID:
12908514
18.

Vaccines against meningococcal meningitis: current status.

[No authors listed]

Epidemiol Bull. 1994 Jul;15(2):13-5. Review. No abstract available.

PMID:
8086300
19.

Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?

Gorringe AR.

Expert Rev Vaccines. 2005 Jun;4(3):373-9. Review.

PMID:
16026250
Items per page

Supplemental Content

Write to the Help Desk